Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.

Clark PE
Expert Rev Anticancer Ther. 2009 9 (6): 821-30

PMID: 19496719 · DOI:10.1586/era.09.36

MeSH Terms (10)

Biomarkers, Tumor Chemotherapy, Adjuvant Combined Modality Therapy Disease Progression Humans Muscle Neoplasms Neoadjuvant Therapy Neoplasm Invasiveness Risk Factors Urinary Bladder Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities:

Links